NONCLASSICAL ANTIMETABOLITES .15. BRIDGE PRINCIPLE OF SPECIFICITY WITH ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS .6. HIGHLY SELECTIVE IRREVERSIBLE INHIBITION OF LACTIC DEHYDROGENASE

被引：28

作者：

BAKER, BR

PATEL, RP

机构：

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1964年 / 53卷 / 07期

关键词：

D O I：

10.1002/jps.2600530703

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：714 / &

相关论文

共 26 条

[1] NON-CLASSICAL ANTIMETABOLITES .6. 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR [J].

BAKER, BR ;

LEE, WW ;

TONG, E .

JOURNAL OF THEORETICAL BIOLOGY, 1962, 3 (03) :459-&

[2] POTENTIAL ANTICANCER AGENTS .66. NON-CLASSICAL ANTIMETABOLITES .3. 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR OF GLUTAMIC DEHYDROGENASE [J].

BAKER, BR ;

LEE, WW ;

ROSS, LO ;

TONG, E .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1961, 83 (17) :3713-&

[3] ANALOGS OF TETRAHYDROFOLIC ACID .6. N-[1-(2-AMINO-4-HYDROXY-6-METHYL-5-PYRIMIDYL)-3-PROPYL] PARA AMINOBENZOYL-L-GLUTAMIC ACID, AN INHIBITOR OF FOLIC REDUCTASE [J].

BAKER, BR ;

MORREAL, CE .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1962, 51 (06) :596-&

[4] POTENTIAL ANTICANCER AGENTS .78. NONCLASSICAL ANTIMETABOLITES .4. SYNTHESIS OF COMPOUNDS RELATED TO 4-(IODOACETAMIDO)SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR [J].

BAKER, BR ;

ROSS, LO ;

MARTINEZ, AP ;

LEE, WW ;

GOODMAN, L .

JOURNAL OF ORGANIC CHEMISTRY, 1962, 27 (09) :3283-&

[5] NONCLASSICAL ANTIMETABOLITES .13. SIMULATION OF 5'-PHOSPHORIBOSYL MOETY OF 5'-ADENYLIC ACID AT ENZYME LEVEL BY OMEGA-CARBOXYALKYL AND ARALKYL GROUPS ATTACHED TO ADENINE [J].

BAKER, BR ;

SACHDEV, HS .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (10) :933-&

[6] NONCLASSICAL ANTIMETABOLITES .12. BRIDGE PRINCIPLE OF SPECIFICITY WITH EXO-ALKYLATING IRREVERSIBLE INHIBITORS .5. DIFFERENCES IN SPECIFICITY OF ENZYMIC NUCLEOPHILIC SITES AS DETECTED BY CARBOPHENOXY GROUP [J].

BAKER, BR ;

PATEL, RP .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (10) :927-&

[7] NON-CLASSICAL ANTIMETABOLITES .9. BRIDGE PRINCIPLE OF SPECIFICITY WITH EXO-ALKYLATING IRREVERSIBLE INHIBITORS .3. DETECTION OF DIFFERENCES IN SPECIFICITY OF ENZYMIC NUCLEOPHILIC SITES BY CARBOPHENOXY GROUP [J].

BAKER, BR ;

PATEL, RP .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1962, 9 (03) :199-&

[8] POTENTIAL ANTICANCER AGENTS .50. NON-CLASSICAL ANTIMETABOLITES .2. SOME FACTORS IN THE DESIGN OF EXO-ALKYLATING ENZYME INHIBITORS, PARTICULARLY OF LACTIC DEHYDROGENASE [J].

BAKER, BR ;

LEE, WW ;

SKINNER, WA ;

MARTINEZ, AP ;

TONG, E .

JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1960, 2 (06) :633-657

[9] NONCLASSICAL ANTIMETABOLITES .14. SOME FACTORS IN DESIGN OF IRREVERSIBLE INHIBITORS EFFECTIVE AT LOW CONCENTRATION [J].

BAKER, BR ;

ALMAULA, PI ;

PATEL, RP .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (11) :1051-&

[10] NON-CLASSICAL ANTIMETABOLITES .8. BRIDGE PRINCIPLE OF SPECIFICITY WITH EXO-ALKYLATING IRREVERSIBLE INHIBITORS [J].

BAKER, BR .

BIOCHEMICAL PHARMACOLOGY, 1962, 11 (DEC) :1155-&